Quantum-Si Incorporated (QSI) vs TriSalus Life Sciences, Inc. (TLSI)

Quantum-Si Incorporated and TriSalus Life Sciences, Inc. are both Medical Devices companies. Quantum-Si Incorporated is the larger, with a market value of $286.7M against $240.1M — 1.2× the size. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against −53.0%. TriSalus Life Sciences, Inc. has the higher net margin (−127.0% vs −6,138.3%) and the higher return on invested capital (0.00% vs −100.9%). Across the 17 metrics below, TriSalus Life Sciences, Inc. leads on 12 and Quantum-Si Incorporated on 5.

Valuation

Metric QSI TLSI Medical Devices median
P/E n/m n/m 23.22
P/S 151.99 4.69 2.34
P/B 1.35 32.31 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 82.37 4.41 2.24
Earnings yield (41.07%) (35.81%) (10.09%)
Free cash flow yield (38.41%) (11.33%) (8.47%)

Profitability

Metric QSI TLSI Medical Devices median
Gross margin 35.02% 85.79% 56.01%
Operating margin (6,887.79%) (67.68%) (15.03%)
Net margin (6,138.26%) (127.00%) (20.40%)
Free cash flow margin (5,837.26%) (51.56%) (7.24%)
Return on equity (49.11%) 889.44% (15.32%)
Return on assets (43.98%) (110.34%) (19.72%)
Return on invested capital (100.92%) 0.00% (10.33%)

Growth

Metric QSI TLSI Medical Devices median
Revenue growth (TTM) (52.96%) 25.25% 8.80%
EPS growth (last fiscal year) 28.17% (40.46%) 29.03%
Revenue growth, 5-year CAGR — — 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QSI TLSI Medical Devices median
Debt to equity 0.00 5.05 0.07
Current ratio 9.97 5.35 2.50
Net debt to EBITDA 1.36 (0.50) 0.49

Dividend

Metric QSI TLSI Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric QSI TLSI Medical Devices median
Market cap 286.74m 240.14m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack